Article
Publicly Available
Imitation and modification of bioactive lead structures via integration of boron clusters
-
Sven Stadlbauer
Published/Copyright:
May 22, 2012
Online erschienen: 2012-5-22
Erschienen im Druck: 2012-5-22
© 2013 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Preface
- A unique, two-component sensing system for fluorescence detection of glucose and other carbohydrates
- Frustrated Lewis pairs: Some recent developments
- Nucleophilic boron strikes back
- Heterometallic cubane-type clusters containing group 13 and 16 elements
- Derivatization chemistry of the double-decker dicobalt sandwich ion targeted to design biologically active substances
- Catalytic enantioselective transformations of borylated substrates: Preparation and synthetic applications of chiral alkylboronates
- Polyhedral borane derivatives: Unique and versatile structural motifs
- Imitation and modification of bioactive lead structures via integration of boron clusters
- Nanotechnology-driven chemistry of boron materials
- Isotope incorporation using organoboranes
- Synthesis and oxidation of hexafluoroisopropoxyborylferrocenes
- Identification of heat shock protein 60 as the regulator of the hypoxia-inducible factor subunit HIF-1α
- (2R,3R)-1,4-Dimethoxy-1,1,4,4-tetraphenylbutane-2,3-diol: Valuable reagent in the asymmetric synthesis of organoboronates
- Boron-based pronucleophiles in catalytic (asymmetric) C(sp3)–allyl cross-couplings
- Complexity-generating hydration reactions via gold-catalyzed addition of boronic acids to alkynes
- Progress toward red and near-infrared (NIR) emitting saccharide sensors
- Boron and carbon: Antagonistic or complementary? Proposal for a simple prototype of a molecular clutch or molecular switch
- Using halo (het) arylboronic species to achieve synthesis of foldamers as protein–protein interaction disruptors
- Carbohydrate biomarker recognition using synthetic lectin mimics
Keywords for this article
asborin;
boron neutron capture therapy (BNCT);
carbaboranes;
carboranes;
cyclooxygenase (COX) inhibitors;
indomethacin derivatives;
neuropeptide Y (NPY)-carbaborane conjugates;
nonsteroidal anti-inflammatory drugs (NSAIDs);
pharmacophores;
phosphonates;
tumor selectivity
Articles in the same Issue
- Preface
- A unique, two-component sensing system for fluorescence detection of glucose and other carbohydrates
- Frustrated Lewis pairs: Some recent developments
- Nucleophilic boron strikes back
- Heterometallic cubane-type clusters containing group 13 and 16 elements
- Derivatization chemistry of the double-decker dicobalt sandwich ion targeted to design biologically active substances
- Catalytic enantioselective transformations of borylated substrates: Preparation and synthetic applications of chiral alkylboronates
- Polyhedral borane derivatives: Unique and versatile structural motifs
- Imitation and modification of bioactive lead structures via integration of boron clusters
- Nanotechnology-driven chemistry of boron materials
- Isotope incorporation using organoboranes
- Synthesis and oxidation of hexafluoroisopropoxyborylferrocenes
- Identification of heat shock protein 60 as the regulator of the hypoxia-inducible factor subunit HIF-1α
- (2R,3R)-1,4-Dimethoxy-1,1,4,4-tetraphenylbutane-2,3-diol: Valuable reagent in the asymmetric synthesis of organoboronates
- Boron-based pronucleophiles in catalytic (asymmetric) C(sp3)–allyl cross-couplings
- Complexity-generating hydration reactions via gold-catalyzed addition of boronic acids to alkynes
- Progress toward red and near-infrared (NIR) emitting saccharide sensors
- Boron and carbon: Antagonistic or complementary? Proposal for a simple prototype of a molecular clutch or molecular switch
- Using halo (het) arylboronic species to achieve synthesis of foldamers as protein–protein interaction disruptors
- Carbohydrate biomarker recognition using synthetic lectin mimics